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Abstract
Mass spectrometry (MS) is a powerful analytical tool with many applications in pharma-
ceutical and biomedical field. The increase in sensitivity and resolution of the instrument 
has opened new dimensions in analysis of pharmaceuticals and complex metabolites of 
biological systems. Compared with other techniques, mass spectroscopy is only the tech-
nique for molecular weight determination, through which we can predict the molecular 
formula. It is based on the conversion of the sample into ionized state, with or without 
fragmentation which are then identified by their mass-to-charge ratios (m/e). Mass spec-
troscopy provides rich elemental information, which is an important asset to interpret 
complex mixture components. Thus, it is an important tool for structure elucidation of 
unknown compounds. Mass spectroscopy also helps in quantitative elemental analysis, 
that is, the intensity of a mass spectra signal is directly proportional to the percentage 
of corresponding element. It is also a noninvasive tool that permits in vivo studies in 
humans. Recent research has looked into the possible applications of mass spectrometers 
in biomedical field. It is also used as a sensitive detector for chromatographic techniques 
like LC–MS, GC–MS and LC/MS/MS. These recent hyphenated technological develop-
ments of the technique have significantly improved its applicability in pharmaceutical 
and biomedical analyses.
Keywords: mass spectrometry, pharmaceutical, biomedical, phytochemical, structure 
elucidation
1. Introduction
Mass spectrometry (MS) is an advanced technique for determining the molecular weight of a 
compound. The first mass spectrometer was developed in 1912 by J.J. Thompson. The instrument 
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has now a wide range of applications in pharmaceutical (drug discovery, pharmacokinetics, 
drug metabolism), clinical (neonatal screening, hemoglobin analysis, drug testing), environmen-
tal (water quality, food contamination, pollutant determination), geological (oil composition, 
hydrocarbon fraction determination in petroleum industry), metallurgy (determination of rare 
earth metals and metals at ppq (parts per quadrillion)), sports (dope test of drugs in athletes), 
forensic (poison and drug metabolite determination) and biotechnology (proteins, peptide anal-
ysis) like fields.
2. Principle
The mass spectroscopy is based on the positive ion generation. For its most popular model, 
the electron impact ionization with magnetic sector analyzer, the sample under investiga-
tion is converted into vapor phase and bombarded with electrons having energy sufficient to 
knock out one electron from it (>10 eV) to produce a positively charged ion called molecular 
ion or parent ion which is denoted by M+.
Positively charged molecule M+ is often unstable, and with increase in energy (10–70 eV) 
according to bond strength, they break into fragments called fragment or daughter ion 
which is denoted by M+1. Ions formed are separated in analyzer under the influence of 
electric and magnetic field and are recorded by the detector to give rise a mass spectrum 
(Figure 1).
Figure 1. Ionization of molecule by electron bombardment.
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3. Components of mass spectrometer
Mass spectrometer mainly consists of following components:
1. Inlet system
2. Ion generation chamber
3. Analyzer tube
4. Ion collector
5. Data collection system
The inlet system transfers the gaseous form of sample into the vacuum of the ion generation 
chamber of mass spectrometer. In the ion generation chamber, neutral sample molecules are 
ionized and then accelerated into the mass analyzer tube. The mass analyzer tube is the most 
important part on which a range of the mass spectrometer depends. This segment separates 
generated ions, either in space or in time, according to their mass-to-charge ratio (m/e). Once 
the ions are separated, they are collected and detected in ion collector chamber. Then, the 
signal is transferred to a data collection system for data investigation. The high vacuum is 
applied between the ion generation chamber, analyzer tube and ion collector. The vacuum 
system is maintaining the low pressure which minimizes the chances of ion-molecule reac-
tion, scattering and neutralization of the ions (Figure 2).
4. Applications
4.1. Phytochemical analysis
Mass spectroscopy is widely employed in phytochemical analysis due to its capabil-
ity to identify and measure metabolites having very low molecular weight at very low 
concentration ranges below nanogram per milliliter (ng/mL). Therefore, it is considered 
as trace analysis methodology. A variety of analyte separation techniques like capillary 
electrophoresis, gas chromatography and high-performance liquid chromatography are 
Figure 2. Components of mass spectrometer.
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united with mass spectroscopy for simultaneous separation and determination of analytes 
called CE-MS, GC–MS and HPLC-MS, respectively. Mass spectrometers like quadrupole 
or quadrupole-time-of-flight (Q-TOF) are frequently employed in combination along with 
gas chromatographic system. Several phytoconstituents are volatile and thermolabile, and 
they can be analyzed by electrospray ionization (ESI) and matrix-assisted laser desorption 
ionization (MALDI). ESI is commonly employed in HPLC-MS and CE-MS. Fourier trans-
form ion cyclotron resonance (FT-ICR), orbitrap and TOF are emerged as high-performance 
mass analyzers that are able to screen metabolites with fraction of seconds due to their 
high resolution. Combination of TOF with one (Q-TOF) or two quadrupoles (Qq-TOF) is 
emerged as hybrid mass spectrometers that are able to cover unlimited mass range with 
high scan rates up to 106 u/s and high resolving power. Analytes having high molecular 
weight and temperature sensitive can be efficiently analyzed by HPLC coupled with atmo-
spheric pressure ionization-mass spectrometer (API-MS) [1]. Some of the recent research 
articles depicting the application of mass spectrometry for the phytochemical analysis are 
listed in Table 1.
S. no. Analytical 
technique
Sample source Analytes Reference
1 HPLC-ESI-MS Leontopodium species 
(Asteraceae)
Fatty acids, sucrose, diterpenes, 
sesquiterpene
[2]
2 GC × GC–MS Essential oil of Pelargonium 
graveolens
ɑ-Pinene, myrcene, limonene, citrinellal, 
geraniol
[3]
3 GC–MS Methanolic fruit extract of 
Momordica charantia
Vitamin E, gentisic acid, 1-pentadecyne [4]
4 GC–MS Extracts of Aerva lanata (R)-(+)-ç-Valerolactone, 5,14-di (N-butyl)-
octadecane, 9-octadecenoic acid, 
2-propynoic acid
[5]
5 GC–MS Ethanolic extract of Azolla 
microphylla
(R)-(+)-ç-Valerolactone, 5,14-di (N-butyl)-
octadecane, 9-octadecenoic acid, 
2-propynoic acid
[6]
6 UHPLC-ESI-MS Rhizopus microsporus var. oryzae 
challenged soya bean seedlings
Prenylated isoflavonoids and isoflavonoids 
like daidzein, genistein, glycitein
[7]
7 HPLC-ESI-MS/
MS
Radix astragali Calycosin, calycosin-7-O-β-D-glycoside, 
formononetin, formononetin-7-O-glycoside
[8]
8 HPLC–MS/MS Glycyrrhiza uralensis Fisch. 
extract
Glycyrrhizic acid, liquorice saponin G2, 
liquiritin, licuraside, ononin, glycycoumarin
[9]
9 LC/MS/MS Dried plums Hydroxycinnamics, including acids, esters 
and glycosides; hydroxybenzoic acids and 
one flavonoid
[10]
10 UHPLC–MS Licorice root extract in 70% 
ethanol, ethanol and ethyl 
acetate
Prenylated flavonoids [11]
Table 1. Applications of mass spectroscopy in phytochemical analysis.
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4.2. Structure elucidation
Mass spectroscopy has major use in structure elucidation of compounds. Mass spectrum is 
produced in the form of bar graph which is interpreted by using the following peaks.
1. Base peak: It is the most intense peak of the mass spectrum. It has 100% abundance.
2. Molecular ion peak: It has highest mass-to-charge ratio (m/e) in mass spectrum created due 
to loss of one electron from molecule, and its m/e value roughly represents the molecular 
weight of compound.
3. Isotopic peaks: Isotopic peaks are often seen in the mass spectrum due to the presence of iso-
topes. These are usually one or two mass units higher or lower than the ion peak. It can be 
represented by m + 1 and m + 2 for one and two molecular weight higher isotopes and vice 
versa for lower weight isotopes. Intensity of the peak depends on the natural abundance of 
isotopes. These are often used as characteristic of a compound for identification.
4. Fragment ion peak: Peak of fragment ion in mass spectrum is called fragment ion peak. 
Fragmentation pattern is characteristic for a particular organic compound. So we can con-
firm the compound by comparing with the library of fragmentation pattern of reference 
compounds.
5. Metastable ion peak: This ion is formed from the disintegration of fragment ion in the ana-
lyzer tube of mass spectrometer. It is generated due to loss of kinetic energy of ion during 
acceleration from ionization chamber to analyzer tube. This ion appears in the spectrum 
at m/e ratio, which depends upon the mass of original ion from which it is formed  ( m 1 + ) 
and fragment ion mass  ( m 2 
+ ) . Metastable ion peaks usually appear at nonintegral values of 
m/e ratio and are often seen as broad peaks. This is used for the confirmation of proposed 
fragmentation pattern of a molecule.
  m ∗  =   ( m 2 
+) 2 
 _____
 ( m 1 
+) 
 
Here, m* is the mass of metastable ion observed in mass spectrum.
There are some rules which are employed in interpretation of mass spectra in structure eluci-
dation process. These are:
1. Nitrogen rule: Nitrogen rule gives very useful clue about the presence or absence and num-
ber of nitrogen atoms. It is divided into two parts:
i. If m/e value of molecular ion peak is odd number, then it may contain odd number of 
nitrogen atoms.
ii. If m/e value of molecular ion peak is even number, then it may or may not contain even 
number of nitrogen atoms.
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2. Hydrogen deficiency index (HDI): Number of pairs of hydrogen required to saturate the 
compound is called hydrogen deficiency index (HDI). Hydrogen deficiency index is also 
called unsaturation index which gives the information about the number of π-bonds and/
or rings present in a molecular structure.
Steps for determination of hydrogen deficiency index:
1. Make the correction in the predicted base formula with respect to the elements obtained 
from other spectral data, and the correction requires addition or removal of hydrogen at-
oms, which depends upon the type of element added.
A. For group V elements (N, P, As, Sb, Bi): Addition of one hydrogen atom is required with 
each added element.
B. For group VI elements (O, S, Se, Te): There is no need of addition of any hydrogen atom 
in the formula.
C. For group VII elements (F, Cl, Br, I): The removal of one hydrogen atom is required with 
each added element.
2. After specific needed corrections, compare molecular formula of unknown compound 
with the formula of saturated hydrocarbon.
3. Calculate the difference in hydrogen atoms between two formulas and corresponding 
pairs of hydrogen atom.
Interpretation of hydrogen deficiency index:
1. If hydrogen deficiency index is one, there must be one double bond or one ring present in 
the structure.
2. If hydrogen deficiency index is two, there must be triple bond or two double bonds, two 
rings, or one double bond and one ring present in the structure.
3. Similarly, benzene ring has hydrogen deficiency index four because it contains three dou-
ble bonds and one ring in it.
4. Any substance with hydrogen deficiency index four or more possibly contains a benzenoid 
ring in it, and the compounds with hydrogen deficiency index less than four cannot con-
tain such type of ring.
We can understand this application by the following examples:
Example 1: Calculate the HDI of C2H4.
C2H4 has two carbon atoms. Therefore, base molecular formula will be:
=C
n
H2n+2.
=C2H(2 × 2)+2.
=C2H6.
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Hydrogen atoms in predicted base molecular formula = 6.
Hydrogen atoms in actual molecular formula of compound = 4.
Difference in hydrogen atoms between two formulas (6–4) = 2 (which corresponds to one pair 
of hydrogen atom).
Hydrogen deficiency index is 1, because one pair of hydrogen atom is required to saturate 
the compound.
Example 2: Calculate the HDI of C
6
H
6
.
C
6
H
6
 has six carbon atoms. Therefore, base molecular formula will be:
=C
n
H2n+2.
=C
6
H(2 × 6)+2.
=C
6
H14.
Hydrogen atoms in predicted base molecular formula = 14.
Hydrogen atoms in actual molecular formula of compound = 6.
Difference in hydrogen atoms between two formulas (14–6) = 8 (which corresponds to four 
pairs of hydrogen atom).
Hydrogen deficiency index is 4, because four pairs of hydrogen atoms are required to saturate 
the compound.
Fragmentation pattern is also an important component of mass spectra from which qualitative 
analysis of compounds can be done, and it is also useful in elucidation of structural arrange-
ment of compound. From Beynon table, one can predict the possible elemental arrangement 
or composition of particular mass and determine the molecular formula of compound. The 
following examples from the literature support the present application of mass spectroscopy.
The structure of flavonoid monoglycosides like genistein-7-O-glucoside, genistein-4′-O-
glucoside, 2′-hydroxygenistein-7-O-glucoside and apigenin, isolated from shoot of lupin 
(Lupinus luteus L.), was elucidated by using LSI-MS and EI-MS with double-focusing reversed 
geometry between mass spectrometer [12].
The analysis of sulfated heparin-like glycosaminoglycan oligosaccharides was done with the 
help of tandem mass spectroscopy (MS/MS) using quadrupole ion trap mass spectrometer and 
quadrupole orthogonal acceleration time-of-flight mass spectrometer, and their fragmentation 
pattern was also studied. This study suggested the use of tandem mass instruments like Q-TOF 
and metal cations in mass spectroscopy of heparin-like glycosaminoglycan oligosaccharides [13].
A one-step complete analysis method was developed for galacto-oligosaccharide mixtures 
obtained in lactose transgalactosylation using β-galactosidase from Aspergillus oryzae based on ion-
mobility spectrometry-tandem mass spectrometry (IMS-MS/MS) with electrospray ionization [14].
The characterization of commercial prebiotic galacto-oligosaccharide mixture was done with 
linear ion-trap mass spectrometer coupled with high-performance anion-exchange chromatog-
raphy (HPAEC) using electrospray ionization combination with 1H NMR and 13C NMR [15].
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The synthesis of a novel sequence of di- and tri-organotin (IV) compounds which contains 
germanium having the general formula R4−nSnLn along with characterization was performed by elemental analysis, FT-IR, multinuclear NMR (1H,13C,119Sn) and mass spectrometry by dou-
ble-focusing mass spectrometer [16].
The characterization of polyisobutylenes was done by various mass spectrometry techniques 
like tandem mass spectroscopy with MALDI-TOF and ESI-QIT. The primary structure was 
determined by multistage mass spectrometric analysis, the presence of specific functional 
groups (e.g., OH or OCH
3
) was confirmed, and also differentiation between isomeric func-
tional groups was done [17].
4.3. Peptide and protein sequence/structure analysis
Mass spectroscopy has an important application in analysis of sequence of amino acids 
in proteins and peptides, that is, analysis of structure of proteins and peptides, and this is 
employed increasingly. This can be performed by stepwise hydrolysis accompanied with 
chromatography. Peptides are converted into amino alcohols which are volatile in nature. 
These amino alcohols derivatized and analyzed in mass spectrometer which aids sequence 
analysis. However, sequencing of underivatized peptides as in fast atom bombardment mass 
spectrometry (FABMS) is also employed. New techniques like MALDI and tandem mass 
spectroscopy are also in trend [18, 19]. Various examples from the literature support the pres-
ent application.
The peptide sequence was analyzed using combination of gas-phase ion/ion chemistry and 
tandem mass spectrometry. The quadrupole linear ion trap with electrospray ionization and 
chemical ionization was also utilized in the analysis to characterize the primary structure of 
intact proteins [20].
Similarly, RNA polymerase II (Pol II) transcription initiation complex structure was analyzed 
by cross-linking and mass spectroscopy. They employed linear ion trap quadrupole (LTQ)-
orbitrap spectrometer and recorded Fourier transform mass spectrometer (FTMS) spectra at 
100,000 resolutions. The cross-linking/MS was used as an integrated structure analysis tool for 
large multi-protein complexes [21].
A new procedure was revealed which enabled selective sequencing and detection of serine-, 
threonine- and tyrosine-phosphopeptides at very low level of femto mole in protein digests 
with electrospray mass spectroscopy (ES-MS) using quadrupole mass spectrometer [22].
Another similar study revealed a method for determination of amino acid sequence of frac-
tions of peptides from apolipoprotein B by tandem mass spectrometry. In this, triple quadru-
pole mass spectrometer along with LSI-MS was employed [23].
4.4. Clinical studies
Implementation of mass spectroscopy in clinical laboratory resulted in significant advance-
ments. Sometimes greater degree of sensitivity is required when analyte quantity is too low and 
mass spectroscopy due to its higher sensitivity marks a valuable place in clinical analysis [24]. In 
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any disease condition, the chemistry of body changes which results in the changes in products 
in body fluids and excretion products can be detected for the diagnosis purpose by chromato-
graphic instrument like gas chromatography equipped with mass spectroscopy [18]. Matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS) is now in trend that is used 
to directly analyze and image pharmaceutical compounds in intact tissue [25].
Organic acidurias are an inherited disorder of metabolism in man, and gas chromatography 
coupled with mass spectroscopy is used to define an organic aciduria involving isovaleric 
acid. This technique is used in diagnosis and characterization of inborn errors of organic 
acid metabolism [26]. A simplified method was developed for clinical diagnosis of organic 
aciduria with gas chromatography–mass spectrometry (GC–MS) using quadrupole mass 
spectrometer. The urine samples were analyzed from patients, and acids were identified like 
methylcitric acid, margaric acid and glutaric acid [27].
Matrix-assisted laser desorption/ionization imaging mass spectrometry is emerged as a 
potent instrument for the investigation of small molecules and proteins in biological systems 
by in situ analysis of tissue sections [28]. A new technique was developed for the identifica-
tion of proteins on tissue using tryptic digestion followed by matrix-assisted laser desorp-
tion/ionization imaging mass spectrometry with tandem mass spectrometry analysis. They 
used MALDI-TOF for their study [29]. Likewise, the level of antitumor drug SCH 226374 was 
determined in mouse tumor tissue using MALDI-QqTOF mass spectrometer. In whole brain 
homogenates, the concentration of drug was determined at nanogram levels with high-per-
formance liquid chromatography/tandem mass spectrometry using triple quadrupole mass 
spectrometer [25].
Matrix-assisted laser desorption ionization-Fourier transform ion cyclotron resonance 
(MALDI-FTICR) is also an efficient technique for imaging of drugs and metabolites in tissue. 
A method based on MALDI-FTICR for imaging of olanzapine in kidney and liver as well as 
imatinib in glioma was described [30].
There is dramatic amplification in interest and implementation of clinical mass spectrometry 
for testing of vitamin D. LC–MS/MS method enables to distinguish between vitamin D2 and vitamin D
3
 and also provides information on the vitamin D epimeric form, both of which are 
not currently possible with existing immunoassays. Mass spectroscopy is the favored method 
for endocrine disorders analysis, for example, steroid analysis which requires technical com-
petence, skill and experience for the needed improvement [24].
Mass spectroscopy can also be used for the investigation of bile acids in biological fluids. Bile 
has bile acids as the major constituents which are synthesized in liver and secreted in gall blad-
der or in intestine. Bile acids have many vital physiological functions like lipid absorption and 
cholesterol homeostasis. Under normal healthy condition, only small quantities of bile acids 
are found in peripheral circulation and urine, but in hepatobiliary and intestinal diseases it 
will get affected. This occurs due to disturbances in synthesis and pharmacokinetics in the 
body. Hence, the evaluation of bile acid can become useful for investigating the liver or intes-
tinal functions along with the diagnosis of various diseases such as cholestasis, colon and liver 
cancer. The complex structure and low concentration of bile acids in biological fluids make 
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their analysis technically difficult. For many years, GC–MS has been used but LC–MS has also 
been used for qualitative analysis of bile acids. A rapid, accurate, sensitive and reproducible 
method was developed using liquid chromatography–electrospray tandem mass spectrom-
etry (LC–MS/MS) to investigate conjugated and total bile acids in samples of human bile and 
mixture of bile acid standards. The results coincide with the results obtained by the GC–MS 
technique. This method has important advantages over others because of the high specificity, 
sensitivity and selectivity of tandem mass spectrometry [31].
Mass spectroscopy has also application in clinical microbiology. Matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been freshly adapted 
for the recognition of whole microorganisms from their colonies on media or directly from 
cultures in blood and urine. This technique can precisely identify even those bacteria which 
are difficult by conventional methods and that day is not far away when this technology will 
complement the conventional microbiologic identification methods. In this technique, a por-
tion of an isolated colony is loaded in the instrument and the comparison of spectrogram is 
done to a library by a proprietary algorithm to identify the organism. The ease of use, ability 
to run large numbers of isolates per batch, simplicity of setup, automation, rapid turnaround 
time and low reagent costs are the major advantages. By optimization, the cost of operation 
reduces to one-tenth that of conventional method with automated biochemical testing plat-
forms. A Swiss study has done a comparison between MALDI-TOF MS system and conven-
tional methods for the identification of 1371 routine bacteria and yeast isolates. MALDI-TOF 
MS provided identifications for 98.5% of the isolates, including 93.2% at the species level 
and 5.3% at the genus level. Of the species-level identifications, 95.1% matched conventional 
identifications. Important deficiencies in present MALDI-TOF MS platforms include misclas-
sification such as of Shigella as Escherichia coli and Streptococcus pneumoniae as Streptococcus 
mitis and, additionally, poor performance with polymicrobial samples. In some cases, instru-
ments have identified only one organism without indicating the presence of others. Despite 
the need for improvement, mass spectrometry will become popular in the near future with 
fast turnaround times, ease of use and potential operational cost savings [32].
4.5. Pharmaceutical analysis
Mass spectroscopy emerged as a powerful tool for various operations in pharmaceutical field 
mainly in drug development. New methods and instruments in mass spectroscopy are devel-
oped at a very high rate. Mass spectroscopy now becomes an irreplaceable tool in all types of 
drug discoveries due to its high sensitivity, speed, versatility and selectivity [33].
Mass spectroscopy is widely used for detection of impurities in samples. Likewise, the 
use of LC–MS for multidimensional evaluation of impurities during drug development is 
described. They used peptide drugs as an example and used ion trap mass spectrometer 
with electrospray ionization in their method [34]. Similarly, it can also be used for detect-
ing the purity profile of active pharmaceutical ingredients (API), that are, MK-0969, an M3 
antagonist; MK-0677, an oral-active growth hormone secretagogue and API-A, a cathepsin 
K inhibitor. The elucidation of impurity structure was made by utilization of LC–MS using 
quadrupole ion trap mass spectrometer equipped with an electrospray ionization or an 
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atmospheric pressure chemical ionization (APCI) interface [35]. A protocol for qualitative 
and quantitative analysis of pharmaceutical compounds by MALDI-TOF mass spectrom-
etry was described. Two drugs lopinavir and ritonavir were analyzed and described that 
HIV protease inhibitors can successfully be quantified in peripheral blood mononuclear cells 
using MALDI-TOF mass spectrometry [36].
Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) 
emerged as a valuable tool in direct analysis of pharmaceutical formulations. MALDI-MSI 
can be used for direct analysis of homogeneity of the active drug compound throughout 
the excipients contained in tablets. A direct analysis in real-time ion source coupled with a 
time-of-flight mass spectrometer (DART-MS) method for screening of pharmaceutical for-
mulations was developed. A library of compounds were analyzed using mass spectra data 
collected by DART-MS operated in switching mode at 20, 60 and 90 V settings. This library 
consisted of 17 commonly encountered drugs in parenteral pharmaceutical formulations, that 
is, surgical analgesic: fentanyl, hydromorphone and morphine; anesthetic: baclofen, bupiva-
caine, ketamine, midazolam, ropivacaine and succinylcholine; and a mixture of other drug 
classes: caffeine, clonidine, dexamethasone, ephedrine, heparin, methadone, oxytocin and 
phenylephrine [37].
4.6. Forensic applications
In forensic study, sample is in minute quantity; therefore, high sensitivity is required for 
analysis. Mass spectroscopy coupled with gas chromatography emerged as an indispensable 
tool in forensic field as well as LC–MS has also wide utility in forensic study. In forensic stud-
ies, the use of mass spectroscopy is becoming significant because of increase in the demand 
to investigate use of illegal drugs through analyzing body fluids and tissues. The sample 
for forensics in the case of drug abuse is mainly urine, hair and blood. Some of the drugs in 
routine analysis include opiates, cocaine, marihuana, lysergic acid diethylamide (LSD) and 
amphetamines. However, cases of murders or death due to poisoning and drug overdose are 
also the prime targets for these drug candidates’ analysis [38].
A liquid chromatographic thermospray tandem mass spectrometric method was developed 
for quantitative analysis of some drugs having hypnotic, sedative and tranquilizing prop-
erties, that is, benzodiazepine, thioxanthene, butyrophenone, methadone and diphenyl-
butylpiperidine in whole blood. A triple-stage quadrupole mass spectrometer was used in 
the analysis at a very low detection limit of 0.05–0.5 ng/ml [39]. Similarly, a method was 
developed for determining common drugs of abuse in body fluids using liquid chromatogra-
phy-atmospheric pressure chemical ionization mass spectrometry (LC-APCI-MS). Drugs ana-
lyzed were opiate agonists (morphine, morphine-3-glucuronide, morphine-6-glucuronide, 
6-monoacetylmorphine, codeine, codeine-6-glucuronide, dihydrocodeine, dihydromorphine, 
buprenorphine, methadone, tramadol, and ibogaine), cocaine and its metabolites (benzoy-
lecgonine and ecgonine methyl ester) and lysergic acid diethylamide in serum, blood, urine 
and other biological matrices by using single quadrupole instrument [40]. Determination of 
11-nor-9-D-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in urine [41], alfentanil, 
fentanyl and its derivatives with other opioid drugs like morphine, buprenorphine, codeine, 
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heroin, methadone, naloxone, naltrexone, tramadol, pentazocine, pethidine and others in hair 
[42] has been done by LC–MS and LC–MS/MS. Analysis of methadone and its metabolites 
with other illicit drugs like cocaine, phencyclidine, heroin and 6-acetylmorphine in hair by 
GC–MS is another successful application of mass spectroscopy [43].
4.7. Metabolites analysis
Determination of metabolic pathway and different metabolites of a drug or xenobiotics is 
very important to assess its different parameters of pharmacokinetics. Drug metabolic reac-
tions can be divided into two parts: 1. Phase I or functionalization reactions and 2. Phase II or 
conjugation reactions. Both of these transformations involve changes in the molecular weight. 
These changes can be accurately measured by mass spectrometer.
In structural characterization by mass spectrometry, the exchange of labile hydrogen with 
deuterium (H/D exchange) in small organic molecules has been widely used and this occurs 
in solution containing functional groups which have labile hydrogen(s) such as -SH, −OH, 
−N(R)H, −NH2 and -COOH. During biotransformation, attachment of polar functional groups occurs, which causes changes in the number of exchangeable hydrogens. The number of 
exchangeable hydrogens in metabolites can give additional information to facilitate struc-
tural elucidation. This approach was applied to differentiate sulfoxide and sulfone metabo-
lites from the isomeric mono- and di-hydroxylated metabolites, respectively. For example, 
the H/D exchange method was used for the drug metabolism studies of denopamine and 
promethazine in which N- or S-oxide was easily distinguished from the hydroxylated metab-
olites. A triple-stage quadrupole mass spectrometer equipped with electron impact (EI), FAB, 
APCI, ESI and thermospray (TSP) systems was utilized in the study [44].
Oxidation of a tertiary amino group to form an N-oxide is an important biotransformation 
pathway for many drugs and xenobiotics. N-oxide metabolites have the same elemental 
composition as those metabolites resulting from hydroxylation. Differentiation by mass spec-
trometry is a challenging task because these analytes exhibit the same m/z for their proton-
ated or deprotonated molecules and their product ion mass spectra are usually very similar. 
Deoxygenation of N-oxides during atmospheric pressure chemical ionization represents 
potential way to differentiate N-oxides from hydroxylated metabolites. 6-OH desloratadine 
and N-oxides can be clearly differentiated as the major fragment ion from N-oxides was due 
to the loss of an oxygen atom while the prominent fragment ion from 6-OH desloratadine was 
due to loss of H2O [45].
Stable isotope-labeled (2H, 13C, 15N, 18O, 34S and others) xenobiotics can facilitate metabolite 
detection and identification by mass spectrometry, especially when radiolabeled parent drug 
is not available [46–48]. Custom-designed isotopic clusters resulting from the mixture of natu-
ral and synthetically enriched isotopes can greatly facilitate the detection and identification 
of metabolites. For example, the detection and identification of ribavirin metabolites in rats 
was done with the aid of stable isotope labeled drug [49]. Similarly, a fast and sensitive liq-
uid chromatography–tandem mass spectrometry method was developed for simultaneous 
determination of acetaminophen and its glucuronide and sulfate metabolites (APAP-GLU 
and APAP-SUL) in small plasma volumes. The tandem triple quadrupole mass spectrometer 
equipped with an electrospray ionization source was used in the study [50].
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5. Conclusion
Mass spectrometry is a very sensitive technique which can analyze even minute quantities of 
the molecule. This ability is utilized for various purposes like phytochemical, clinical, phar-
maceutical and forensic analyses. This technique, not only elucidates the structure of the com-
pounds, but also provides the information of molecular formula and the isotopic abundance 
of particular molecular formula. The availability of interphases made it possible to hyphenate 
this sophisticated technique with the different chromatographic techniques. This opened the 
new horizons of its applicability. The variations and permutation combinations of different 
ionization techniques with the different analyzers provide the analysis of diversified chemical 
entities at the femtogram level. The uniqueness of the technique of making fragments of the 
compound under investigation provides valuable structural information. This is helpful in 
the study of metabolite, peptide sequencing and macromolecules. This information is directly 
applicable in pharmaceutical and biomedical analysis. The development of double and triple 
quad techniques and their application have definitely uplifted the level of research and analy-
sis in biomedical field, and this chapter gives the update on the topic.
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